These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26496203)

  • 41. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
    Alvarez Cubero MJ; Lorente JA; Robles-Fernandez I; Rodriguez-Martinez A; Puche JL; Serrano MJ
    Methods Mol Biol; 2017; 1634():283-303. PubMed ID: 28819860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
    Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microfluidic-Based Enrichment and Retrieval of Circulating Tumor Cells for RT-PCR Analysis.
    Gogoi P; Sepehri S; Chow W; Handique K; Wang Y
    Methods Mol Biol; 2017; 1634():55-64. PubMed ID: 28819840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.
    Lyberopoulou A; Aravantinos G; Efstathopoulos EP; Nikiteas N; Bouziotis P; Isaakidou A; Papalois A; Marinos E; Gazouli M
    PLoS One; 2015; 10(4):e0123902. PubMed ID: 25902072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optofluidic device for the quantification of circulating tumor cells in breast cancer.
    Pedrol E; Garcia-Algar M; Massons J; Nazarenus M; Guerrini L; Martínez J; Rodenas A; Fernandez-Carrascal A; Aguiló M; Estevez LG; Calvo I; Olano-Daza A; Garcia-Rico E; Díaz F; Alvarez-Puebla RA
    Sci Rep; 2017 Jun; 7(1):3677. PubMed ID: 28623262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.
    Neves RP; Raba K; Schmidt O; Honisch E; Meier-Stiegen F; Behrens B; Möhlendick B; Fehm T; Neubauer H; Klein CA; Polzer B; Sproll C; Fischer JC; Niederacher D; Stoecklein NH
    Clin Chem; 2014 Oct; 60(10):1290-7. PubMed ID: 25267515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel microfluidic model can mimic organ-specific metastasis of circulating tumor cells.
    Kong J; Luo Y; Jin D; An F; Zhang W; Liu L; Li J; Fang S; Li X; Yang X; Lin B; Liu T
    Oncotarget; 2016 Nov; 7(48):78421-78432. PubMed ID: 27191997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
    Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
    Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells.
    Warkiani ME; Guan G; Luan KB; Lee WC; Bhagat AA; Chaudhuri PK; Tan DS; Lim WT; Lee SC; Chen PC; Lim CT; Han J
    Lab Chip; 2014 Jan; 14(1):128-37. PubMed ID: 23949794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.
    Matthew EM; Zhou L; Yang Z; Dicker DT; Holder SL; Lim B; Harouaka R; Zheng SY; Drabick JJ; Lamparella NE; Truica CI; El-Deiry WS
    Oncotarget; 2016 Jan; 7(4):3662-76. PubMed ID: 26695546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
    Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
    Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
    Bobek V; Gurlich R; Eliasova P; Kolostova K
    World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
    Riethdorf S; Fritsche H; Müller V; Rau T; Schindlbeck C; Rack B; Janni W; Coith C; Beck K; Jänicke F; Jackson S; Gornet T; Cristofanilli M; Pantel K
    Clin Cancer Res; 2007 Feb; 13(3):920-8. PubMed ID: 17289886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
    Chen X; Wang X; He H; Liu Z; Hu JF; Li W
    PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients.
    Hyun KA; Kwon K; Han H; Kim SI; Jung HI
    Biosens Bioelectron; 2013 Feb; 40(1):206-12. PubMed ID: 22857995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
    Lu J; Fan T; Zhao Q; Zeng W; Zaslavsky E; Chen JJ; Frohman MA; Golightly MG; Madajewicz S; Chen WT
    Int J Cancer; 2010 Feb; 126(3):669-83. PubMed ID: 19662651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.